Deutsche Bank’s Billion Private Credit Bet Roils Shares
Deutsche Bank revealed a $30 billion private credit exposure, roughly 2.1% of its asset base, triggering a stock pull...
Which Region Etf Pays The Highest Dividend
This guide compares region-focused ETFs to highlight which region pays the highest dividend and what factors influence payouts.
21,913 articles
Oof! Federal Reserve's Inflation Forecast and Market Turmoil
The Fed's May inflation outlook caught investors off guard and sparked a rethink of risk, rates, and returns. This gu...
Here's Ryanair Stock Flew Higher Today: Key Drivers
Ryanair stock moved higher after better-than-expected Q4 results and improving profitability. This article breaks dow...
Calumet (CLMT) 2026 Earnings Outlook: A Deep Dive
This article breaks down calumet (clmt) 2026 earnings into actionable insights. Learn how to read the Q1 transcript, ...
Oracle Upside According Wall Street Analysts Shifts
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
Has Chevron Found Growth Platform? A Clear Investor Guide
Investors are weighing whether Chevron’s recent steps point to a new growth platform. This deep dive explains what a ...
Oracle Stock Plummeted First Half 2026: AI Risks Unveiled
Oracle stock plummeted first as AI ambitions collided with debt and customer risk. This article breaks down the why, ...
American Silver (PAAS) Earnings: PAAS Stock Insights
Dig into the drivers behind PAAS earnings and what they reveal about American silver mining. This guide explains how ...
EOSE Stock Despite Volatile: Navigating a Solar Storage Play
EOSE stock has surged in a volatile stretch as investors weigh grid-scale storage growth against project risks. This ...
Why a Full Exit From Cogent Could Matter to Investors
A steep stock drop can force tough choices. This article analyzes why a full exit from Cogent could matter to investo...
Investors Tell Companies to Invest as Growth Wins Now
Investors are shifting money toward growth initiatives, pressuring companies to expand and innovate instead of increa...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status